Retinal detachment repair is a specialized ophthalmic surgical intervention performed to correct structural separation of the inner layers of the retina from the outer wall of the eye. The primary goal of intervention is anatomical reattachment, halting progressive visual field loss and protecting central visual acuity. Mechanisms involve relieving vitreous traction, sealing underlying retinal breaks with retinopexy (laser or cold therapy), and re-establishing tissue apposition using internal gas/oil bubbles or external scleral bands. Interventions fall under vitreoretinal surgery, an advanced subspecialty of ophthalmology.

Retinal detachment repair is executed under sterile operating room conditions utilizing micro-incision vitreoretinal surgical systems. For primary Pars Plana Vitrectomy (PPV), the surgeon places three 23-, 25-, or 27-gauge trocars through the sclera (white wall of the eye). Intraocular illumination and micro-cutters are inserted to systematically excise the vitreous gel and relieve mechanical traction surrounding retinal tears. Subretinal fluid is evacuated using a specialized needle, re-approximating the retina against the eye wall. Laser photocoagulation (endo-laser) or a cold probe (cryopexy) is applied around every break to create a permanent chorioretinal scar. Finally, an intraocular tamponade agent—either an expandable gas mixture (SF6 or C3F8) or silicone oil—is injected to press the retina firmly into position during scar maturation. In Scleral Buckling, a flexible silicone band is sutured externally to the outer wall of the eye, indenting the sclera inward to neutralize vitreous traction over the retinal break, usually paired with external cryopexy and transscleral fluid drainage. Pneumatic Retinopexy is an office-based alternative where a gas bubble is injected directly into the vitreous cavity, followed by cryopexy or post-bubble laser.

Surgical intervention for retinal detachment offers definitive evidence-based clinical benefits grounded in vitreoretinal outcomes research (American Academy of Ophthalmology Preferred Practice Pattern 2024):

• Anatomical Reattachment: Primary single-operation success rates range between 85% and 95% depending on baseline severity and procedure selection.
• Preservation of Vision: Emergency repair in "macula-on" cases prevents catastrophic central vision loss, preserving pre-detachment visual acuity in over 90% of patients.
• Visual Field Retention: Halts the expansion of progressive dark curtains or shadows (scotomas) in the peripheral vision.
• Prevention of Ocular Atrophy: Prevents chronic intraocular inflammation, hypotony (pathologically low eye pressure), and ultimate globe atrophy (phthisis bulbi).

Recovery from retinal detachment repair follows a structured timeline dictated by surgical technique and intraocular tamponade materials:

• Days 1–14: Strict head positioning (e.g., face-down) is required if a gas or oil bubble was used. Visual acuity is markedly reduced by intraocular gas. Mild to moderate ocular discomfort, redness, and eyelid swelling are managed with prescribed analgesics and eye drops.
• Weeks 2–6: Intraocular gas bubbles slowly reabsorb (short-acting gas dissolves in 2–3 weeks; long-acting gas in 6–8 weeks). Patients note a shifting fluid level in their vision as the bubble shrinks. Return to sedentary desk work is often permitted, though heavy lifting and vigorous activities remain strictly restricted. Air travel and high-altitude exposure are forbidden while gas remains in the eye.
• Months 2–6: Gradual visual acuity stabilization occurs. Patients who underwent vitrectomy typically experience accelerated cataract development within 6 to 24 months. Patients with silicone oil tamponade undergo a secondary minor procedure for oil removal.

Retinal detachment repair is indicated for several severe intraocular pathologies, including:

• Rhegmatogenous retinal detachment (RRD): Detachment caused by a full-thickness tear or hole allowing fluid inside the eye to enter the subretinal space.
• Tractional retinal detachment (TRD): Detachment resulting from fibrovascular scar tissue pulling the retina off the back wall, common in advanced diabetic retinopathy.
• Exudative (serous) retinal detachment: Secondary fluid accumulation beneath the retina without a physical break, managed surgically when secondary to structural lesions or tumors.
• Giant retinal tears (GRT): Full-thickness retinal breaks extending 90 degrees or more around the circumference of the globe.
• Retinal dialyses: Traumatic or developmental separations of the retina at its anterior border (the ora serrata).

Pre-operative preparation requires a meticulous diagnostic workup. The patient undergoes a complete dilated fundus examination using binocular indirect ophthalmoscopy with scleral depression to locate all retinal breaks and map areas of detachment. High-resolution Optical Coherence Tomography (OCT) evaluates macular involvement, while B-scan ultrasonography visualizes structural details if dense vitreous hemorrhage obscures optical view. Systemic evaluation includes assessing cardiovascular status and blood pressure control. Patients taking antiplatelet or anticoagulant medications are managed according to individual risk guidelines, though systemic blood thinners are frequently continued safely during micro-incision vitrectomy. Pre-operative fasting is required for 6 to 8 hours if moderate sedation or general anesthesia is planned. Patients are instructed to prepare their domestic environment for post-operative face-down positioning, often renting specialized recovery chairs or mirrors.

Complications of retinal detachment repair are stratified by frequency and clinical impact. Common, expected side effects include transient elevation of intraocular pressure, ocular redness, corneal surface irritation, and post-vitrectomy cataract progression (occurring in over 80% of phakic patients within two years). Less common complications include recurrent retinal detachment due to Proliferative Vitreoretinopathy (PVR)—a scar tissue reaction occurring in 5% to 10% of cases requiring secondary intervention—vitreous hemorrhage, subretinal gas or fluid accumulation, and choroidal detachment. Rare but sight-threatening risks include endophthalmitis (severe internal bacterial infection, <0.05%), suprachoroidal hemorrhage, hypotony (abnormally low intraocular pressure), retinal pigment epithelium tears, and permanent ischemic vision loss.

The clinical journey begins with an urgent ophthalmic evaluation, including dilated fundus examination, high-resolution optical coherence tomography, and indirect ophthalmoscopy to locate all retinal breaks and assess macular status. Surgery is typically performed on an urgent or emergent basis in an outpatient ambulatory setting under local anesthesia with sedation or general anesthesia. Intraoperatively, the surgeon relieves physical traction, seals breaks using laser photocoagulation or cryopexy, and applies mechanical tamponade. Post-operatively, patients follow strict head positioning protocols to maintain bubble contact against the healing retina, adhere to anti-inflammatory and antibiotic eye drop regimens, and attend frequent follow-up examinations over 3 to 12 months to monitor anatomical healing and visual recovery.